Disequilibrium: Difference between revisions
No edit summary |
No edit summary |
||
Line 49: | Line 49: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[3-methylglutaconic aciduria]], [[Leukoencephalopathy|4H syndrome]], [[abetalipoproteinemia]], [[adrenoleukodystrophy]], [[adrenomyeloneuropathy]], [[alpha-mannosidase deficiency]], [[AMACR|alpha-methylacyl-CoA racemase deficiency]], [[Andermann syndrome]], [[argininosuccinic aciduria]], [[Metachromatic leukodystrophy|arylsulphatase A deficiency]], [[aspartoacylase deficiency]], [[ataxia-telangiectasia]], [[Cutis laxa|ATP6V0A2-related cutis laxa]], [[bilateral frontoparietal polymicrogyria]], [[biotinidase deficiency]], [[carbamoylphosphate synthetase deficiency]], [[carbohydrate deficient glycoprotein syndrome type 1a]], [[CCFDN syndrome]], [[SACS (gene)|Charlevoix-Saguenay spastic ataxia | |bgcolor="Beige"| [[3-methylglutaconic aciduria]], [[Leukoencephalopathy|4H syndrome]], [[abetalipoproteinemia]], [[adrenoleukodystrophy]], [[adrenomyeloneuropathy]], [[alpha-mannosidase deficiency]], [[AMACR|alpha-methylacyl-CoA racemase deficiency]], [[Andermann syndrome]], [[argininosuccinic aciduria]], [[Metachromatic leukodystrophy|arylsulphatase A deficiency]], [[aspartoacylase deficiency]], [[ataxia-telangiectasia]], [[Cutis laxa|ATP6V0A2-related cutis laxa]], [[bilateral frontoparietal polymicrogyria]], [[biotinidase deficiency]], [[carbamoylphosphate synthetase deficiency]], [[carbohydrate deficient glycoprotein syndrome type 1a]], [[CCFDN syndrome]], [[SACS (gene)|Charlevoix-Saguenay spastic ataxia]], [[Cockayne syndrome]], [[Mitochondrial disease|coenzyme Q10 deficiency]], [[dentatorubral-pallidoluysian atrophy]], [[Fabry's disease]], [[familial alphalipoprotein deficiency]], [[Friedreich's ataxia]], [[Hyperkalemic periodic paralysis|Gamstorp-Wohlfart syndrome]], [[glucose phosphate isomerase deficiency]], [[GM2 gangliosidosis]], [[Griscelli syndrome]], [[Haw river syndrome]], [[hereditary neuralgic amyotrophy]], [[Huntington disease]], [[hypobetalipoproteinemia]], [[Joubert syndrome]], [[Loken Senior syndrome]], [[Marinesco-Sjogren syndrome]], [[MELAS]], [[MERRF]], [[Biotinidase deficiency|multiple carboxylase deficiency]], [[Navajo neurohepatopathy]], [[Phenylketonuria|phenylalanine hydroxylase deficiency]], [[Pitt-Hopkins syndrome]], [[progressive external ophthalmoplegia]], [[Refsum disease]], [[Revesz syndrome]], [[Roussy-Levy disease]], [[Sandhoff disease ]], [[SeSAME syndrome]], [[Silver syndrome]], [[SPG20|Troyer syndrome]], [[Unverricht-Lundborg disease]], [[Van der Knaap disease]], [[Von Hippel-Lindau syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| [[Anemia]], [[glucose phosphate isomerase deficiency]], [[haemochromatosis]], [[leukemia]], [[multiple myeloma]], [[pernicious anemia]], | |bgcolor="Beige"| [[Anemia]], [[glucose phosphate isomerase deficiency]], [[haemochromatosis]], [[leukemia]], [[multiple myeloma]], [[pernicious anemia]], [[plasmacytoma]], [[polycythemia vera]], [[sideroblastic anemia ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 61: | Line 61: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Infectious Disease''' | | '''Infectious Disease''' | ||
|bgcolor="Beige"| [[Acute | |bgcolor="Beige"| [[Acute necrotizing myelopathy]], [[acute viral myelitis]], [[borrelia burgdorferi]], [[botulism]], [[brainstem encephalitis]], [[brucellosis]], [[cerebellar abscess]], [[chickenpox]], [[coxsackie disease]], [[cysticercosis]], [[cytomegalovirus polyradiculopathy]], [[diphtheria]], [[encephalomyelitis]], [[endophthalmitis]], [[epidural abscess]], [[epstein-barr virus]], [[Guillain-Barré syndrome]], [[herpes simplex]], [[herpes zoster]], [[HIV]], [[infectious cerebellitis]], [[leprosy]], [[lyme disease]], [[malaria]], [[meningoencephalitis]], [[mycoplasma pneumoniae]], [[ophthalmia neonatorum]], [[osteomyelitis]], [[polymyositis]], [[schistosoma]], [[septic arthritis]], [[septicemia]], [[syphilis]], [[tick paralysis]], [[transient synovitis]], [[treponema pallidum]], [[tuberculosis]], [[typhoid fever]], [[viral hepatitis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 105: | Line 105: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| [[Acute demyelinating encephalomyelitis]], [[ankylosing spondylitis]], [[antiphospholipid antibody syndrome]], [[benign monoclonal gammopathy]], [[connective tissue disease]], [[dermatomyosistis]], [[fibromyalgia]], [[gout]], [[Guillain-Barré syndrome]], [[lymphomatoid granulomatosis]], [[microscopic polyangiitis]], [[mixed connective tissue disease]], [[monoclonal gammopathy]], [[polyarteritis nodosa]], [[pseudogout]], [[Reiter's syndrome]], [[rheumatoid arthritis]], [[scleroderma]], [[seronegtive arthropathy]], [[Sjögren's syndrome]], [[systemic lupus erythematosus]] | |bgcolor="Beige"| [[Acute disseminated encephalomyelitis natural history, complications and prognosis|Acute demyelinating encephalomyelitis]], [[ankylosing spondylitis]], [[antiphospholipid antibody syndrome]], [[benign monoclonal gammopathy]], [[connective tissue disease]], [[dermatomyosistis]], [[fibromyalgia]], [[gout]], [[Guillain-Barré syndrome]], [[lymphomatoid granulomatosis]], [[microscopic polyangiitis]], [[mixed connective tissue disease]], [[monoclonal gammopathy]], [[polyarteritis nodosa]], [[pseudogout]], [[Reiter's syndrome]], [[rheumatoid arthritis]], [[scleroderma]], [[seronegtive arthropathy]], [[Sjögren's syndrome]], [[systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 135: | Line 135: | ||
*[[Acrylamide]] | *[[Acrylamide]] | ||
*[[Acute coronary syndrome]] | *[[Acute coronary syndrome]] | ||
*[[Acute demyelinating encephalomyelitis]] | *[[Acute disseminated encephalomyelitis natural history, complications and prognosis|Acute demyelinating encephalomyelitis]] | ||
*[[Acute intermittent porphyria]] | *[[Acute intermittent porphyria]] | ||
*[[Acute necrotizing myelopathy]] | *[[Acute necrotizing myelopathy]] | ||
Line 223: | Line 223: | ||
*[[Chlorpheniramine]] | *[[Chlorpheniramine]] | ||
*[[Chondroma]] | *[[Chondroma]] | ||
*[[Chronic liver disease]] | *[[Chronic liver disease]] | ||
*[[Chronic obstructive pulmonary disease exacerbation]] | *[[Chronic obstructive pulmonary disease exacerbation]] | ||
Line 231: | Line 230: | ||
*[[Claude syndrome]] | *[[Claude syndrome]] | ||
*[[Clomifene ]] | *[[Clomifene ]] | ||
*[[Cockayne syndrome]] | *[[Cockayne syndrome]] | ||
*[[Coenzyme Q10 deficiency]] | *[[Mitochondrial disease|Coenzyme Q10 deficiency]] | ||
*[[Colchicine]] | *[[Colchicine]] | ||
*[[Cold exposure]] | *[[Cold exposure]] | ||
Line 300: | Line 298: | ||
*[[Fibromyalgia]] | *[[Fibromyalgia]] | ||
*[[Fluorouracil]] | *[[Fluorouracil]] | ||
*[[ | *[[Friedreich's ataxia]] | ||
*[[Gamma-diketone hexacarbons]] | *[[Gamma-diketone hexacarbons]] | ||
*[[Gamstorp- | *[[Hyperkalemic periodic paralysis|Gamstorp-Wohlfart syndrome]] | ||
*[[Genaralized weakness]] | *[[Genaralized weakness]] | ||
*[[Gerstmann-sträussler-scheinker syndrome]] | *[[Gerstmann-sträussler-scheinker syndrome]] | ||
Line 310: | Line 308: | ||
*[[Gm2 gangliosidosis]] | *[[Gm2 gangliosidosis]] | ||
*[[Gout]] | *[[Gout]] | ||
*[[Griscelli syndrome | *[[Griscelli syndrome]] | ||
*[[Guillain-barré syndrome]] | *[[Guillain-barré syndrome]] | ||
*[[Haemochromatosis]] | *[[Haemochromatosis]] | ||
Line 378: | Line 376: | ||
*[[Linezolid]] | *[[Linezolid]] | ||
*[[Lithium ]] | *[[Lithium ]] | ||
*[[Loken | *[[Loken Senior syndrome]] | ||
*[[Lower motor neuron weakness]] | *[[Lower motor neuron weakness]] | ||
*[[Lumbosacral plexitis]] | *[[Lumbosacral plexitis]] | ||
Line 410: | Line 408: | ||
*[[Motor neuron syndrome]] | *[[Motor neuron syndrome]] | ||
*[[Multifocal motor neuropathy]] | *[[Multifocal motor neuropathy]] | ||
*[[Multiple carboxylase deficiency]] | *[[Biotinidase deficiency|Multiple carboxylase deficiency]] | ||
*[[Multiple hamartoma syndrome]] | *[[Multiple hamartoma syndrome]] | ||
*[[Multiple lentigines syndrome ]] | *[[Multiple lentigines syndrome ]] | ||
Line 468: | Line 466: | ||
*[[Perthes disease]] | *[[Perthes disease]] | ||
*[[Phaeochromocytoma]] | *[[Phaeochromocytoma]] | ||
*[[Phenylalanine hydroxylase deficiency]] | *[[Phenylketonuria|Phenylalanine hydroxylase deficiency]] | ||
*[[Phenylbutazone ]] | *[[Phenylbutazone ]] | ||
*[[Phenytoin]] | *[[Phenytoin]] | ||
*[[Physostigmine ]] | *[[Physostigmine ]] | ||
*[[Pitt-hopkins syndrome]] | *[[Pitt-hopkins syndrome]] | ||
*[[Plasmacytoma]] | |||
*[[Pleural effusion]] | *[[Pleural effusion]] | ||
*[[Pneumonia]] | *[[Pneumonia]] | ||
Line 527: | Line 526: | ||
*[[Sjögren's syndrome]] | *[[Sjögren's syndrome]] | ||
*[[Slipped upper femoral epiphysis]] | *[[Slipped upper femoral epiphysis]] | ||
*[[Spinal cord tumors]] | *[[Spinal cord tumors]] | ||
*[[Spinal epidural hematoma]] | *[[Spinal epidural hematoma]] | ||
Line 533: | Line 531: | ||
*[[Stavudine]] | *[[Stavudine]] | ||
*[[Strachan syndrome]] | *[[Strachan syndrome]] | ||
*[[Stroke ]] | *[[Stroke]] | ||
*[[Subacute combined degeneration]] | *[[Subacute combined degeneration]] | ||
*[[Subacute necrotising encephalomyelopathy]] | *[[Subacute necrotising encephalomyelopathy]] | ||
Line 557: | Line 555: | ||
*[[Transverse myelitis ]] | *[[Transverse myelitis ]] | ||
*[[Treponema pallidum]] | *[[Treponema pallidum]] | ||
*[[Troyer syndrome]] | *[[SPG20|Troyer syndrome]] | ||
*[[Tuberculosis]] | *[[Tuberculosis]] | ||
*[[Typhoid fever]] | *[[Typhoid fever]] |
Revision as of 23:06, 30 July 2013
WikiDoc Resources for Disequilibrium |
Articles |
---|
Most recent articles on Disequilibrium Most cited articles on Disequilibrium |
Media |
Powerpoint slides on Disequilibrium |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Disequilibrium at Clinical Trials.gov Trial results on Disequilibrium Clinical Trials on Disequilibrium at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Disequilibrium NICE Guidance on Disequilibrium
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Disequilibrium Discussion groups on Disequilibrium Patient Handouts on Disequilibrium Directions to Hospitals Treating Disequilibrium Risk calculators and risk factors for Disequilibrium
|
Healthcare Provider Resources |
Causes & Risk Factors for Disequilibrium |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Vendhan Ramanujam M.B.B.S [2]
Synonyms and keywords: Loss of balance; imbalance; off balance; unsteadiness
Overview
Disequilibrium refers to an impaired sense or absence of balance or equilibrioception, which primarily occurs during standing or walking usually without any cephalic sensations like headache, nausea and vomiting. It is one among the causes of dizziness[1] and is often accompanied by spatial disorientation.
Causes
Life Threatening Causes
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ "Chapter 14: Evaluation of the Dizzy Patient". Retrieved 2009-08-06.